Severe acute respiratory syndrome: historical, epidemiologic, and clinical features

DSC Hui, A Zumla - Infectious Disease Clinics, 2019 - id.theclinics.com
Over the past 2 decades 2 previously unknown coronaviruses (CoVs), the severe acute
respiratory syndrome CoV (SARS-CoV) and the Middle East respiratory syndrome CoV …

Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion

PE Verweij, BJA Rijnders, RJM Brüggemann… - Intensive care …, 2020 - Springer
Purpose Invasive pulmonary aspergillosis is increasingly reported in patients with influenza
admitted to the intensive care unit (ICU). Classification of patients with influenza-associated …

Recent discovery and development of inhibitors targeting coronaviruses

T Pillaiyar, S Meenakshisundaram, M Manickam - Drug discovery today, 2020 - Elsevier
Human coronaviruses (CoVs) are enveloped viruses with a positive-sense single-stranded
RNA genome. Currently, six human CoVs have been reported including human coronavirus …

[HTML][HTML] Chemokines and chemokine receptors during COVID-19 infection

BA Khalil, NM Elemam, AA Maghazachi - Computational and structural …, 2021 - Elsevier
Chemokines are crucial inflammatory mediators needed during an immune response to
clear pathogens. However, their excessive release is the main cause of hyperinflammation …

Pathogenesis of respiratory viral and fungal coinfections

F Salazar, E Bignell, GD Brown, PC Cook… - Clinical Microbiology …, 2022 - Am Soc Microbiol
Individuals suffering from severe viral respiratory tract infections have recently emerged as
“at risk” groups for developing invasive fungal infections. Influenza virus is one of the most …

Coronaviruses—drug discovery and therapeutic options

A Zumla, JFW Chan, EI Azhar, DSC Hui… - Nature reviews Drug …, 2016 - nature.com
In humans, infections with the human coronavirus (HCoV) strains HCoV-229E, HCoV-OC43,
HCoV-NL63 and HCoV-HKU1 usually result in mild, self-limiting upper respiratory tract …

COVID-19-associated opportunistic infections: a snapshot on the current reports

A Abdoli, S Falahi, A Kenarkoohi - Clinical and experimental medicine, 2022 - Springer
Abstract Treatment of the novel Coronavirus Disease 2019 (COVID-19) remains a
complicated challenge, especially among patients with severe disease. In recent studies …

Multi-organ involvement in COVID-19: beyond pulmonary manifestations

V Thakur, RK Ratho, P Kumar, SK Bhatia, I Bora… - Journal of clinical …, 2021 - mdpi.com
Coronavirus Disease 19 (COVID-19), due to severe acute respiratory syndrome coronavirus-
2 (SARS-CoV-2) has become an on-going global health emergency affecting over 94 million …

Diagnosing COVID-19-associated pulmonary aspergillosis

PE Verweij, JP Gangneux, M Bassetti… - The Lancet …, 2020 - thelancet.com
There is increasing concern that patients with coronavirus disease 2019 (COVID-19) might
be at risk of developing invasive pulmonary aspergillosis co-infection. 1 In a cohort of 221 …

Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection

VCC Cheng, SKP Lau, PCY Woo… - Clinical microbiology …, 2007 - Am Soc Microbiol
Before the emergence of severe acute respiratory syndrome (SARS) coronavirus (SARS-
CoV) in 2003, only 12 other animal or human coronaviruses were known. The discovery of …